+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Predictive Genetic Testing And Consumer Genomics Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 155 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5696795

Direct-To-Consumer Genetic Testing is majorly attracting the consumers

The Global Predictive Genetic Testing And Consumer Genomics Market is estimated to be USD 2.09 Bn in 2023 and is expected to reach USD 3.9 Bn by 2028 growing at a CAGR of 13.35%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Predictive Genetic Testing And Consumer Genomics Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Predictive Genetic Testing And Consumer Genomics Market are segmented based on Test Type, Applications, Setting Type, and Geography.
  • By Test Type, the market is classified into Predictive Testing, Consumer Genomics, and Wellness Genomics.
  • By Applications, the market is classified into Cardiovascular screening, Diabetic Screening & Monitoring, Cancer, Parkinsonism / Alzheimer’s Disease, Urologic Screening, and Orthopedic & Musculoskeletal.
  • By Setting Type, the market is classified into DTC and Professional.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Bio-Rad Laboratories, Inc., Cooper Surgical, Inc., Danaher Corp., F. Hoffmann-La Roche Ag, Guardant Health, Inc., Illumina, Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Predictive Genetic Testing And Consumer Genomics Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Predictive Genetic Testing And Consumer Genomics Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Predictive Genetic Testing And Consumer Genomics Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rise in the Number of Novel Partnership Models
4.1.2 Introduction of Fragmented Point-solutions across the Genomics Value Chain
4.1.3 Exponentially Decreasing Costs for Genetic Sequencing
4.2 Restraints
4.2.1 Absence of Well-defined Regulatory Framework and Low Adoption Rate
4.2.2 Ethical Concerns Pertaining to Implementation
4.3 Opportunities
4.3.1 Technological Advancements in Cloud Computing and Data Integration
4.4 Challenges
4.4.1 Defects Observed in Consumer Genetic Kits
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis
6 Global Predictive Genetic Testing And Consumer Genomics Market, By Test Type
6.1 Introduction
6.2 Predictive Testing
6.2.1 Genetic Susceptibility Test
6.2.2 Predictive Diagnostics
6.2.3 Population Screening
6.3 Consumer Genomics
6.4 Wellness Genomics
6.4.1 Nutria Genetics
6.4.2 Skin & Metabolism Genetics
7 Global Predictive Genetic Testing And Consumer Genomics Market, By Applications
7.1 Introduction
7.2 Cardiovascular Screening
7.3 Diabetic Screening & Monitoring
7.4 Cancer
7.5 Parkinsonism / Alzheimer’s Disease
7.6 Urologic Screening
7.7 Orthopedic & Musculoskeletal
8 Global Predictive Genetic Testing And Consumer Genomics Market, By Setting Type
8.1 Introduction
8.2 DTC
8.3 Professional
9 Americas’ Predictive Genetic Testing And Consumer Genomics Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Predictive Genetic Testing And Consumer Genomics Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Predictive Genetic Testing And Consumer Genomics Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Predictive Genetic Testing And Consumer Genomics Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Abbott Laboratories
14.2 Advanced Genomic Solutions (AGS) Ltd.
14.3 Agilent Technologies, Inc.
14.4 ARUP Laboratories
14.5 Bio-Rad Laboratories, Inc.
14.6 Cepheid
14.7 Color Genomics, Inc.
14.8 Cooper Surgical, Inc.
14.9 Danaher Corp.
14.10 F. Hoffmann-La Roche Ag
14.11 Guardant Health, Inc.
14.12 Illumina, Inc.
14.13 Konica Minolta, Inc.
14.14 Labcorp
14.15 Mapmygenome
14.16 Myriad Genetics, Inc.
14.17 Positive Biosciences, Ltd.
14.18 QIAGEN
14.19 Quest Diagnostics, Inc.
14.20 Thermo Fisher Scientific, Inc.
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Advanced Genomic Solutions (AGS) Ltd.
  • Agilent Technologies, Inc.
  • ARUP Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cepheid
  • Color Genomics, Inc.
  • Cooper Surgical, Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ag
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Konica Minolta, Inc.
  • Labcorp
  • Mapmygenome
  • Myriad Genetics, Inc.
  • Positive Biosciences, Ltd.
  • Quest Diagnostics, Inc.
  • Thermo Fisher Scientific, Inc.